Pneumococcal
Pneumococcal Vaccination – Advanced Protection with Capvaxive (PCV21)
Protect yourself against serious pneumococcal infections, including pneumonia, meningitis and sepsis, with our range of pneumococcal vaccines. At Epicare Health, we offer Prevenar 20 (PCV20) and Capvaxive (PCV21), a newer-generation vaccine specifically developed to address the changing strains of pneumococcal bacteria responsible for serious infections in adults.
Why Choose Capvaxive (PCV21) Over Prevenar 20?
A newer generation of pneumococcal protection, designed with today's adult infection risks in mind.
Pneumococcal bacteria are constantly changing. While traditional vaccines have successfully reduced infections caused by many common strains, other strains have become increasingly responsible for serious illnesses such as pneumonia, meningitis and bloodstream infections. Capvaxive (PCV21) has been specifically developed to address this changing pattern of pneumococcal disease in adults.
What Makes Capvaxive Different?
Targets 21 pneumococcal serotypes: Including 11 strains not covered by Prevenar 20.
Designed for adult protection: Its serotype selection focuses on strains responsible for invasive pneumococcal disease in adults.
Coverage reflecting today's infection patterns: Capvaxive includes several emerging strains that have become increasingly important following the success of earlier vaccination programmes.
Long-lasting immune response: As a conjugate vaccine, Capvaxive stimulates immune memory to help the body recognise and respond to the pneumococcal strains it targets.
How Much Broader Is Capvaxive's Coverage?
Recent surveillance data from England (2023–2024) found that the serotypes included in Capvaxive accounted for approximately 81.7% of invasive pneumococcal disease cases, compared with 64.3% for Prevenar 20. This suggests Capvaxive offers broader coverage of the strains currently causing serious invasive infections in England.
These percentages represent the proportion of disease-causing serotypes included in each vaccine, not the percentage of infections that vaccination is proven to prevent.
Is Capvaxive Worth the Additional Cost?
Capvaxive is a premium vaccination option because of its updated, adult-focused serotype coverage. Rather than simply adding another strain, it targets a different selection of pneumococcal bacteria, including several strains not covered by existing conjugate vaccines.
However, Prevenar 20 remains an effective and established vaccination option, and Capvaxive has not been proven to provide superior clinical protection for every individual.
At Epicare Health, our healthcare professionals can assess your age, medical history, risk factors and previous vaccination history to help you choose the most appropriate pneumococcal vaccine.
What Vaccines are available?
The pneumococcal vaccine helps protect against some types of bacterial infections that can cause serious illnesses like:
meningitis (an infection in the brain and spinal cord)
sepsis (a life-threatening reaction to an infection)
pneumonia (an infection in the lungs)
It can also help protect against other illnesses such as sinusitis and ear infections.
Vaccine Schedules
Prevenar 20
Infants and children 6 weeks – 15 months of age (3-dose schedule)
Dose 1: 2 months of age (can be given as early as 6 weeks)
Dose 2: 2 months later
Dose 3: 11–15 months of age
Infants and children 6 weeks – 15 months of age (4-dose schedule / preterm)
Dose 1: 2 months of age (can be given as early as 6 weeks)
Dose 2: At least 4 weeks later
Dose 3: At least 4 weeks later
Dose 4: 11–15 months of age
Unvaccinated infants 7 – 12 months of age
Dose 1: At presentation
Dose 2: At least 4 weeks later
Dose 3: In second year of life
Unvaccinated children 12 – 24 months of age
Dose 1: At presentation
Dose 2: At least 8 weeks later
Unvaccinated children 2 – 5 years of age
Single dose
Children 15 months – 5 years (previously vaccinated)
Single dose (ensure ≥8 weeks since previous pneumococcal vaccine)
Children 5 – 18 years
Single dose (ensure ≥8 weeks since previous pneumococcal vaccine if applicable)
Adults (18+ years)
Single dose
Capvaxive
Infants under 2 years
Not reccomended
Children aged 2 to 17
Recommended single dose if they completed a primary paediatric pneumococcal vaccination
Adults (18+ years)
Single dose
Prevention
Getting vaccinated with the pneumococcal vaccine is one of the best ways to prevent pneumonia.
You can also reduce your risk of viral pneumonia by getting the flu jab and the COVID-19 vaccine.
Need to book more than one vaccine?
Please make a booking for a single vaccine and leave a note with the booking for the other vaccines you require. We will reserve the vaccines and call you if there are any issues.
Note: We offer a 5% discount for cash payments.
Please make sure you fill in the form in the appointment confirmation which you will recieve (as a link). This will allow us to do a risk assessement before your arrive and check all your travel requirements for a swift & safe appointment.
*Note*
Any cancellation, rescheduling, or missed appointment within 48 hours of the scheduled time will result in the loss of the £30 deposit. If you wish to reschedule, a new £30 deposit will be required to secure the new appointment.
Vaccine prices may change due to supplier or manufacturer fluctuations. Prices are guaranteed only when the full course is paid in advance, and vaccines are allocated.
.png)
